Wockhardt Ltd.

In News

Wockhardt Shares Jump More Than 11% After Landmark Acceptance — Here's What You Need To Know - NDTV Profit

NDTV Profit - Dec 02, 2025

Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulin - The Economic Times

The Economic Times - Jul 11, 2025

Wockhardt Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Markets Mojo - Apr 09, 2026

Wockhardt Ltd spurts 3.61%, rises for fifth straight session - Business Standard

Business Standard - Apr 08, 2026

Wockhardt New Drug Application for Breakthrough antibiotic Zaynich accepted by USFDA - Medical Dialogues

Medical Dialogues - Dec 01, 2025

Wockhardt Limited's (NSE:WOCKPHARMA) Price Is Out Of Tune With Revenues - simplywall.st

simplywall.st - Nov 10, 2025

Wockhardt jumps over 19% after USFDA accepts its new drug filing - The Times of India

The Times of India - Dec 01, 2025

Wockhardt shares zoom 20% on this USFDA approval - MSN

MSN - Dec 02, 2025

Wockhardt shares rally 19% after US FDA accepts NDA for breakthrough antibiotic Zaynich - CNBC TV18

CNBC TV18 - Dec 01, 2025

Wockhardt’s Zaynich NDA gets USFDA acceptance: What India’s first NCE means for the company - Moneycontrol.com

Moneycontrol.com - Dec 02, 2025

Wockhardt Ltd Valuation Shifts Signal Changing Market Sentiment - Markets Mojo

Markets Mojo - Apr 11, 2026

Indian pharma Wockhardt seeks US approval for new drug to treat UTIs - The Economic Times

The Economic Times - Oct 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment